<DOC>
	<DOCNO>NCT02759029</DOCNO>
	<brief_summary>Helicobacter pylorus eradication ( H. pylorus ) rate clarithromycin-based triple therapy decline , alternative strategy need urgently . The investigator seek compare efficacy pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy vs. concomitant therapy H. pylorus eradication region high rate multiple drug resistance .</brief_summary>
	<brief_title>Development Treatment Algorithm Eradication Helicobacter Pylori Based Antibiotic Susceptibility Test</brief_title>
	<detailed_description />
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>1. positive result rapid urease test 1. liver cirrhosis , 2. chronic kidney disease , 3. bleeding tendency , 4. pregnant , 5. allergy antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>